US 9603954
Methods for generating radioimmunoconjugates
granted A61KA61K51/1027A61P
Quick answer
US patent 9603954 (Methods for generating radioimmunoconjugates) held by Actinium Phamaceuticals, Inc. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Actinium Phamaceuticals, Inc.
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K51/1027, A61P, A61P35/00